Lexicon Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 10.70M4.91M1.85M
Gross Profit 10.70M4.91M1.85M
Operating items
Research & Development 81.24M78.52M91.83M
Selling, General & Administrative 19.42M19.40M17.35M
Restructuring Costs 2.71M6.77M
Operating Expenses 100.66M100.63M115.94M
Operating Income -89.96M-95.72M-114.09M
EBIT -89.96M-95.72M-114.09M
Non-operating items
Non Operating Investment Income -3.51M0.14M
Interest & Investment Income 0.88M0.52M0.26M
Other Non Operating Income -2.55M-4.02M0.15M
Non Operating Income -2.55M-4.02M0.15M
Net income details
EBT -93.42M-101.80M-116.22M
Tax Provisions -0.10M-0.03M
Profit After Tax -93.32M-101.78M-116.22M
Income from Non-Controlling Interests -10.54M
Income from Continuing Operations -93.32M-101.78M-116.22M
Consolidated Net Income -93.32M-101.78M-116.22M
Income towards Parent Company -93.32M-101.78M-116.22M
Net Income towards Common Stockholders -93.32M-101.78M-116.22M
Additional items
EPS (Basic) 0.15M-0.00M-0.00M
Shares Outstanding (Weighted Average) 25.10M48.22M48.24M73.20M73.36M73.55M103.62M104.04M105.59M105.93M106.27M117.47M148.90M188.73M244.92M361.49M
EBITDA -89.96M-95.72M-114.09M
Tax Rate 0.11%0.03%